Abstract
Background
Charcot-Marie-Tooth type 1A (CMT1A) is an autosomal dominant polyneuropathy due to a 1.5 Mb tandem duplication in chromosome 17p11.2, containing the PMP22 gene. This mutation is not modified during inheritance.
Objectives
We set forth to test the hypothesis that in a subgroup of CMT1A patients there is clinical anticipation, namely an increase in disease severity over generations.
Methods
Thirty-nine CMT1A mutation-positive patients in 16 families and 23 parent-offspring pairs were evaluated. This included 14 families with 2 generations and 2 families with 3 generations. Age of presentation was assessed by interviewing the patients and clinical severity was measured using the CMT neuropathy score (CMTNS).
Results
In 21/23 parent-child pairs and 14/16 families, there was an earlier age of presentation in children of genetically affected parents. The mean age of onset in the progeny was 12.61 years compared to 41.22 years in the parent generation, (p < 0.001).Mean severity in the younger generation was slightly higher than that of the parent generation. When corrected for the age difference, the trend for a worse phenotype in the younger generation became statistically significant (p < 0.02,Wilcoxon signed rank test).
Conclusions
Our findings suggest that in a subgroup of CMT1A patients there is an increase in clinical severity over generations. The mechanism responsible for this observation remains unknown. Our findings should be validated on a larger cohort of CMT1A families.
Similar content being viewed by others
References
Shy ME (2004) Charcot-Marie-Tooth disease: an update. Curr Opin Neurol 17:579–585
Warner LE, Garcia CA, Lupski JR (1999) Hereditary peripheral neuropathies: clinical forms, genetics, and molecular mechanisms. Annu Rev Med 50:263–275
Lupski J, de Oca-Luna R, Slaugenhaupt S, et al. (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219–232
Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, et al. (1991) Duplication in chromosome 17p11. 2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord 1:93–97
Berger P, Young P, Suter U (2002) Molecular cell biology of Charcot-Marie-Tooth disease. Neurogenetics 4:1–15
Warner LE, Hilz MJ, Appel SH, et al. (1996) Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth Type 1B, Dejerine-Sottas and congenital hypomyelination. Neuron 17:451–460
Dupre N, Bouchard JP, Cossette L, et al. (1999) Clinical and electrophysiological study in French-Canadian population with Charcot-Marie-tooth disease type 1A associated with 17p11. 2 duplication. Can J Neurol Sci 26:196–200
Morocutti C, Colazza GB, Soldati G, et al. (2002) Charcot-Marie-Tooth disease in Molise, a central-southern region of Italy: an epidemiological study. Neuroepidemiology 21:241–245
Richards RI (2001) Dynamic mutations: a decade of unstable expanded repeats in human genetic disease. Hum Mol Genet 10:2187–2194
Lindblad K, Schalling M (1999) Expanded repeat sequences and disease. Semin Neurol 19:289–299
Rosenmann H, Kahana E, Korczyn AD, et al. (1999) Preliminary evidence for anticipation in genetic E200K Creutzfeldt-Jakob disease. Neurology 53:1328–1329
Shirahama S, Miyahara A, Kitoh H, et al. (2003) Skewed X-chromosome inactivation causes intra-familial phenotypic variation of an EBP mutation in a family with X-linked dominant chondrodysplasia punctata. Hum Genet 112:78–83
Trkova M, Hladikova M, Kasal P, Goetz P, Sedlacek Z (2002) Is there anticipation in the age at onset of cancer in families with Li-Fraumeni syndrome? J Hum Genet 47:381–386
Cavallini MC, Albertazzi M, Bianchi L, Bellodi L (2002) Anticipation of age at onset of obsessive-compulsive spectrum disorders in patients with obsessivecompulsive disorder. Psychiatry Res 111:1–9
Freeman HJ (2002) Familial Crohn’s disease in single or multiple first-degree relatives. J Clin Gastroenterol 35:9–13
Shy ME, Blake J, Krajewski K, et al. (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209–1214
Cornblath DR, Chaudhry V, Carter K, et al. (1999) Total neuropathy score: validation and reliability study. Neurology 53:1660–1664
Lopes J, LeGuern E, Gouider R, Brice A, et al. (1996) Recombination hot spot in a 3. 2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: new tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie- Tooth type 1A. French CMT Collaborative Research Group. American Journal of Human Genetics 58:1223–1230
Ashizawa T, Conneally PM (1999) Repeats may not be everything in anticipation. Neurology 53:1164–1164
Goncalves A, da Salva JB (1977) Brothers affected by the Charcot-Marie-Tooth peroneal muscular atrophy with a positive variant of the anticipation phenomenon (Article in Portuguese). Arq Neuropsiquiatr 35:167–171
Thornton C (1999) The myotonic dystrophies. Semin Neurol 19:25–33
Bertram L, Tanzi RE (2005) The genetic epidemiology of neurodegenerative disease. J Clin Invest 115:1449–1457. Review
Harley HG, Rundle SA, MacMillan JC, et al. (1993) Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet 52:1164–1174
Snell RG, MacMillan JC, Cheadle JP, et al. (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington’s disease. Nat Genet 4:393–397
Benton CS, de Silva R, Rutledge SL, et al. (1998) Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype. Neurology 51:1081–1086
MacDonald ME, Vonsattel JP, Shrinidhi J, et al. (1999) Evidence for the GluR6 gene associated with younger onset age of Huntington’s disease. Neurology 53:1330–1332
Inoue K, Dewar K, Katsanis N, et al. (2001) The 1. 4-Mb CMT1A duplication/ HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes. Genome Res 11:1018–1033
Presciuttini S, Varesco L, Sala P, et al. (1994) Age of onset in familial adenomatous polyposis: heterogeneity within families and among APC mutations. Ann Hum Genet 58:331–342
Goldberg JM, Piver MS, Jishi MF, Blumenson L (1997) Age at onset of ovarian cancer in women with a strong family history of ovarian cancer. Gynecol Oncol 66:3–9
Hsu L, Zhao LP, Malone KE, Daling JR (2000) Assessing changes in ages at onset over successive generation: an application to breast cancer. Genet Epidemiol 18:17–32
Shugart YY, Hemminki K, Vaittinen P, Kingman A, Dong C (2000) A genetic study of Hodgkin’s lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden. Hum Genet 106:553–556
Gorwood P, Leboyer M, Falissard B, Rouillon MJF, Feingold J (1996) Anticipation in schizophrenia: new light on a controversial problem. Am J Psych 153:1173–1177
Iwai K, Yamamoto M, Yoshihara T, Sobue G (2002) Anticipation in familial amyotrophic lateral sclerosis with SOD1-G93S mutation. J Neurol Neurosurg Psych 72:819–820
Misu K, Hattori N, Ando Y, Ikeda S, Sobue G (2000) Anticipation in earlybut not late-onset familial amyloid polyneuropathy (TTR Met30) in Japan. Neurology 55:451–452
Kovach MJ, Campbell KC, Herman K, et al. (2002) Anticipation in a unique family with Charcot-Marie-Tooth syndrome and deafness: delineation of the clinical features and review of the literature. Am J Med Genet 108:295–303
Höweler CJ, Busch HFM, Geraedts JPM, Niermeijer MF, Staal A (1989) Anticipation in myotonic dystrophy: fact or fiction? Brain 112:779–797
Tawil R, Forrester J, Griggs RC, et al. (1996) Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neurol 39:744–748
Chauvenet AR, Shashi V, Selsky C, et al. (2003) Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a pediatric oncology group study. J Ped Hemat Oncol 25:316–320
Pulst SM, Santos N, Wang D, et al. (2005) Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain 128:2297–2303
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Steiner, I., Gotkine, M., Steiner-Birmanns, B. et al. Increased severity over generations of Charcot-Marie-Tooth disease type 1A. J Neurol 255, 813–819 (2008). https://doi.org/10.1007/s00415-008-0693-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0693-1